Patent · US Active

Receptor inhibitor, pharmaceutical composition comprising same, and use thereof

US11453690B2 · kind B2 · utility

1Cited by

0References

50Claims

0Family size

Assignee

BEIJING TIDE PHARMACEUTICAL CO., LTD. · CN

Inventors

Yanping Zhao · Beijing, CN
Hongjun Wang · Ningbo City, CN
Yeming Wang · Beijing, CN
Xiang Li · Beijing, CN
Yuanyuan Jiang · Beijing, CN
Huai HUANG · Beijing, CN
Fajie LI · Beijing, CN
Liying ZHOU · Beijing, CN
Ning Shao · Clark, US
Fengping XIAO · Beijing, CN
Zhenguang Zou · Beijing, CN

Key dates

Filing date	Mar 22, 2019
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Mar 22, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.